OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales.
about
Sacral neuromodulation in overactive bladder: a review and current perspectivesClinical practice of BOTOX(®) treatment for overactive bladder syndrome in Sweden: an assessment of resource use and external validity.Sacral nerve stimulation versus intravesical botulinum toxin injections for medically refractory overactive bladder: A contemporary review of UK treatment from both clinician and patients’ perspectives
P2860
OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
OnabotulinumtoxinA in the trea ...... ive care in England and Wales.
@en
type
label
OnabotulinumtoxinA in the trea ...... ive care in England and Wales.
@en
prefLabel
OnabotulinumtoxinA in the trea ...... ive care in England and Wales.
@en
P2093
P2860
P1476
OnabotulinumtoxinA in the trea ...... ive care in England and Wales.
@en
P2093
Clara Loveman
Dmitry Gultyaev
Johanna Lister
Kristin Khalaf
Nick Freemantle
Sanja Stanisic
P2860
P2888
P304
P356
10.1007/S10198-015-0737-2
P577
2015-10-19T00:00:00Z